Abstract
Non-melanoma skin cancer (NMSC) is an important cause of morbidity and long-term mortality in organ transplant recipients receiving immunosuppressive drugs such as azathioprine and cyclosporin, often combined with adrenocortical steroids (glucocorticoids). At lower doses, glucocorticoids alone are prescribed for other conditions including musculoskeletal, connective tissue and respiratory disorders. Presently, it is unknown whether patients taking glucocorticoids are at an increased risk of skin malignances. In a population-based case-control study in New Hampshire, USA, we compared use of glucocorticoids in 592 basal cell carcinoma (BCC) and 281 squamous cell carcinoma (SCC) cases and in 532 age and gender matched controls; neither cases nor controls had a history of organ transplantation. Participants underwent a structured personal interview regarding history of medication use and skin cancer risk factors. We used unconditional logistic regression analysis to compute odds ratios associated with glucocorticoid use for 1 month or longer while controlling for potential confounding factors. Risk of SCC was increased among users of oral glucocorticoids (adjusted odds ratio = 2.31; 95% CI = 1.27, 4.18), and risk of BCC was elevated modestly (adjusted odds ratio = 1.49; 95% CI = 0.90, 2.47). In contrast, risk of both SCC and BCC were unrelated to use of inhaled steroids. Our data suggest that use of oral glucocorticoids may increase risk of NMSC, and SCC in particular, among patients other than organ transplant recipients. We hypothesize that immunosuppression induced by oral glucocorticoids may allow these cancers to emerge from immunosurveillance. © 2001 Cancer Research Campaign www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Blohme, I & Larko, O (1984). Premalignant and malignant skin lesions in renal transplant patients. Transplantation, 37, 165–167.
Bouwes Bavinck, JN, Hardie, DR, Green, A, Cutmore, S, MacNaught, A, O’Sullivan, B, Siskind, V, Van Der Woude, FJ & Hardie, IR (1996). The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation, 61, 715–721.
Breslow, N & Day, N (1980). Statistical Methods in Cancer Research. Volume I, The Analysis of Case-Control Studies, IARC: Lyon
Coebergh, JW, Neumann, HA, Vrints, LW, van der Heijden, L, Meijer, WJ & Verhagen-Teulings, MT (1991). Trends in the incidence of non-melanoma skin cancer in the SE Netherlands 1975–1988: a registry-based study. Br J Dermatol, 125, 353–359.
Dyall-Smith, D & Ross, JB (1995). Cutaneous malignancies in renal transplant recipients from Nova Scotia, Canada. Australas Dermatol, 36, 79–82.
Gallagher, RP, Ma, B, McLean, DI, Yang, CP, Ho, V, Carruthers, JA & Warshawski, LM (1990). Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol, 23, 413–421.
Gupta, AK, Cardella, CJ & Haberman, HF (1986). Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol, 122, 1288–1293.
Hardman, JG, Gilman, AG & Limbird, LE (1996). Goodman’s & Gilman’s The Pharmacological Basis of Therapeutics, McGraw-Hill: New York
Hartevelt, MM, Bavinck, JN, Kootte, AM, Vermeer, BJ & Vandenbroucke, JP (1990). Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation, 49, 506–509.
Hoxtell, EO, Mandel, JS, Murray, SS, Schuman, LM & Goltz, RW (1977). Incidence of skin carcinoma after renal transplantation. Arch Dermatol, 113, 436–438.
Jensen, P, Hansen, S, Moller, B, Leivestad, T, Pfeffer, P, Geiran, O, Fauchald, P & Simonsen, S (1999). Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol, 40, 177–186.
Kaldor, J, Shugg, D, Young, B, Dwyer, T & Wang, YG (1993). Non-melanoma skin cancer: Ten years of cancer-registry-based surveillance. Int J Cancer, 53, 886–891.
Karagas, MR, Greenberg, ER, Spencer, SK, Stukel, TA & Mott, LA (1999). Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int J Cancer, 81, 555–559.
Kinlen, L (1996). Immunologic factors, including AIDS. Cancer Epidemiology and Prevention, Schottenfeld D, Fraumeni JJ (eds) 532–545, Oxford University Press: New York
Kripke, ML (1994). Ultraviolet radiation and immunology: something new under the sun – presidential address. Cancer Res, 54, 6102–6105.
Levi, F, Franceschi, S, Te, VC, Randimbison, L & La Vecchia, C (1995). Trends of skin cancer in the Canton of Vaud, 1976–92. Br J Cancer, 72, 1047–1053.
McCann, J (1999). Can skin cancers be minimized or prevented in organ transplant recipients?. J Natl Cancer Inst, 91, 911–913.
O’Connell, BM, Abel, EA, Nickoloff, BJ, Bell, BJ, Hunt, SA, Theodore, J, Shumway, NE & Jacobs, PH (1986). Dermatologic complications following heart transplantation. J Heart Transplant, 5, 430–436.
Radis, CD, Kahl, LE, Baker, GL, Wasko, MCM, Cash, JM, Gallatin, S, Stolzer, BL, Agarwal, AK, Medsger, TA & Kwoh, CK (1995). Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis: a 20-year followup study. Arthritis Rheum, 38, 1120–1127.
Sheiner, PA, Magliocca, JF, Bodian, CA, Kim-Schluger, L, Altaca, G, Guarrera, JV, Emre, S, Fishbein, TM, Guy, SR, Schwartz, ME & Miller, CM (2000). Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation, 69, 781–789.
Staples, M, Marks, R & Giles, G (1998). Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985–1995: are primary prevention programs starting to have an effect?. Int J Cancer, 78, 144–148.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Karagas, M., Cushing, G., Greenberg, E. et al. Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer 85, 683–686 (2001). https://doi.org/10.1054/bjoc.2001.1931
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2001.1931
Keywords
This article is cited by
-
Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy
Nature Reviews Urology (2016)
-
The Wrath of Steroids in Elderly Patients with Pulmonary Diseases
Current Geriatrics Reports (2016)
-
Skin steroidogenesis in health and disease
Reviews in Endocrine and Metabolic Disorders (2016)
